| UniProt ID | CUL5_HUMAN | |
|---|---|---|
| UniProt AC | Q93034 | |
| Protein Name | Cullin-5 | |
| Gene Name | CUL5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 780 | |
| Subcellular Localization | ||
| Protein Description | Core component of multiple SCF-like ECS (Elongin-Cullin 2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition component. ECS(SOCS1) seems to direct ubiquitination of JAK2. Seems to be involved in proteosomal degradation of p53/TP53 stimulated by adenovirus E1B-55 kDa protein. May form a cell surface vasopressin receptor.. | |
| Protein Sequence | MATSNLLKNKGSLQFEDKWDFMRPIVLKLLRQESVTKQQWFDLFSDVHAVCLWDDKGPAKIHQALKEDILEFIKQAQARVLSHQDDTALLKAYIVEWRKFFTQCDILPKPFCQLEITLMGKQGSNKKSNVEDSIVRKLMLDTWNESIFSNIKNRLQDSAMKLVHAERLGEAFDSQLVIGVRESYVNLCSNPEDKLQIYRDNFEKAYLDSTERFYRTQAPSYLQQNGVQNYMKYADAKLKEEEKRALRYLETRRECNSVEALMECCVNALVTSFKETILAECQGMIKRNETEKLHLMFSLMDKVPNGIEPMLKDLEEHIISAGLADMVAAAETITTDSEKYVEQLLTLFNRFSKLVKEAFQDDPRFLTARDKAYKAVVNDATIFKLELPLKQKGVGLKTQPESKCPELLANYCDMLLRKTPLSKKLTSEEIEAKLKEVLLVLKYVQNKDVFMRYHKAHLTRRLILDISADSEIEENMVEWLREVGMPADYVNKLARMFQDIKVSEDLNQAFKEMHKNNKLALPADSVNIKILNAGAWSRSSEKVFVSLPTELEDLIPEVEEFYKKNHSGRKLHWHHLMSNGIITFKNEVGQYDLEVTTFQLAVLFAWNQRPREKISFENLKLATELPDAELRRTLWSLVAFPKLKRQVLLYEPQVNSPKDFTEGTLFSVNQEFSLIKNAKVQKRGKINLIGRLQLTTERMREEENEGIVQLRILRTQEAIIQIMKMRKKISNAQLQTELVEILKNMFLPQKKMIKEQIEWLIEHKYIRRDESDINTFIYMA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Ubiquitination | MATSNLLKNKGSLQF CCCCHHHCCCCCCCC | 60.83 | 33845483 | |
| 10 | Ubiquitination | TSNLLKNKGSLQFED CCHHHCCCCCCCCCC | 48.57 | 29967540 | |
| 12 | Phosphorylation | NLLKNKGSLQFEDKW HHHCCCCCCCCCCCH | 22.17 | 22985185 | |
| 34 | Phosphorylation | LKLLRQESVTKQQWF HHHHHCCCCCHHHHH | 27.09 | 29507054 | |
| 36 | Phosphorylation | LLRQESVTKQQWFDL HHHCCCCCHHHHHHH | 32.20 | 28450419 | |
| 74 | Ubiquitination | EDILEFIKQAQARVL HHHHHHHHHHHHHHH | 44.92 | 29967540 | |
| 82 | Phosphorylation | QAQARVLSHQDDTAL HHHHHHHCCCCCHHH | 19.08 | 29449344 | |
| 87 | Phosphorylation | VLSHQDDTALLKAYI HHCCCCCHHHHHHHH | 27.74 | 29449344 | |
| 123 | Ubiquitination | ITLMGKQGSNKKSNV EEEECCCCCCCCCCH | 36.35 | 21890473 | |
| 124 | Phosphorylation | TLMGKQGSNKKSNVE EEECCCCCCCCCCHH | 42.87 | - | |
| 128 | Phosphorylation | KQGSNKKSNVEDSIV CCCCCCCCCHHHHHH | 47.95 | - | |
| 183 | Phosphorylation | LVIGVRESYVNLCSN EEEEEEHHHHHCCCC | 24.66 | 29083192 | |
| 184 | Phosphorylation | VIGVRESYVNLCSNP EEEEEHHHHHCCCCH | 6.65 | 29083192 | |
| 189 | Phosphorylation | ESYVNLCSNPEDKLQ HHHHHCCCCHHHHHH | 59.59 | 29083192 | |
| 194 | Ubiquitination | LCSNPEDKLQIYRDN CCCCHHHHHHHHHHH | 40.40 | 29967540 | |
| 210 | Phosphorylation | EKAYLDSTERFYRTQ HHHHHHCCCHHHHCC | 30.74 | 18669648 | |
| 231 | Ubiquitination | QNGVQNYMKYADAKL HCCHHHHHHHHHHHC | 3.34 | 24816145 | |
| 232 | Ubiquitination | NGVQNYMKYADAKLK CCHHHHHHHHHHHCH | 27.25 | 32015554 | |
| 237 | Ubiquitination | YMKYADAKLKEEEKR HHHHHHHHCHHHHHH | 61.72 | 29967540 | |
| 268 | Ubiquitination | LMECCVNALVTSFKE HHHHHHHHHHHHHHH | 5.30 | 21890473 | |
| 286 | Acetylation | AECQGMIKRNETEKL HHHHHHHHCCCHHHH | 40.03 | 30587963 | |
| 325 | Ubiquitination | IISAGLADMVAAAET HHHHHHHHHHHHHHH | 36.81 | 21890473 | |
| 346 | Phosphorylation | KYVEQLLTLFNRFSK HHHHHHHHHHHHHHH | 37.58 | 20068231 | |
| 356 | Ubiquitination | NRFSKLVKEAFQDDP HHHHHHHHHHHCCCC | 54.48 | 29967540 | |
| 373 | Phosphorylation | LTARDKAYKAVVNDA CCHHHHHHHHHHCCC | 12.76 | 16497976 | |
| 384 | Ubiquitination | VNDATIFKLELPLKQ HCCCEEEEEEECCCC | 36.88 | 21890473 | |
| 397 | Ubiquitination | KQKGVGLKTQPESKC CCCCCCCCCCCHHHC | 38.90 | 29967540 | |
| 433 | Ubiquitination | TSEEIEAKLKEVLLV CHHHHHHHHHHHHHH | 47.50 | 24816145 | |
| 447 | Acetylation | VLKYVQNKDVFMRYH HHHHHCCCCHHHHHH | 37.87 | 24468231 | |
| 455 | Acetylation | DVFMRYHKAHLTRRL CHHHHHHHHHHHHHH | 28.68 | 24468241 | |
| 463 | Ubiquitination | AHLTRRLILDISADS HHHHHHHHEECCCCC | 2.85 | 23000965 | |
| 466 | Ubiquitination | TRRLILDISADSEIE HHHHHEECCCCCHHH | 3.07 | 23000965 | |
| 467 | Ubiquitination | RRLILDISADSEIEE HHHHEECCCCCHHHH | 26.20 | 23000965 | |
| 470 | Ubiquitination | ILDISADSEIEENMV HEECCCCCHHHHHHH | 39.94 | 21890473 | |
| 492 | Ubiquitination | MPADYVNKLARMFQD CCHHHHHHHHHHHHH | 33.22 | 24816145 | |
| 529 | Ubiquitination | PADSVNIKILNAGAW CCCCCCEEEECCCCC | 35.62 | 21890473 | |
| 537 | Phosphorylation | ILNAGAWSRSSEKVF EECCCCCCCCCCCEE | 23.04 | 29514088 | |
| 539 | Phosphorylation | NAGAWSRSSEKVFVS CCCCCCCCCCCEEEE | 37.02 | 29514088 | |
| 540 | Phosphorylation | AGAWSRSSEKVFVSL CCCCCCCCCCEEEEC | 40.08 | 29514088 | |
| 620 | Ubiquitination | KISFENLKLATELPD HCCHHHHHHHHCCCC | 47.89 | - | |
| 631 | Methylation | ELPDAELRRTLWSLV CCCCHHHHHHHHHHH | 22.50 | - | |
| 633 | Phosphorylation | PDAELRRTLWSLVAF CCHHHHHHHHHHHHC | 26.58 | 24670416 | |
| 656 | Phosphorylation | LYEPQVNSPKDFTEG EECCCCCCCCCCCCC | 34.17 | - | |
| 665 | Ubiquitination | KDFTEGTLFSVNQEF CCCCCCCCEEECHHH | 4.41 | 23000965 | |
| 668 | Ubiquitination | TEGTLFSVNQEFSLI CCCCCEEECHHHHHH | 7.21 | 23000965 | |
| 669 | Ubiquitination | EGTLFSVNQEFSLIK CCCCEEECHHHHHHH | 34.17 | 23000965 | |
| 673 | Phosphorylation | FSVNQEFSLIKNAKV EEECHHHHHHHCCCC | 28.56 | 24719451 | |
| 695 | Phosphorylation | LIGRLQLTTERMREE EEEEEECCHHHHHHH | 17.41 | 21722762 | |
| 696 | Phosphorylation | IGRLQLTTERMREEE EEEEECCHHHHHHHH | 30.13 | 21722762 | |
| 724 | Neddylation | EAIIQIMKMRKKISN HHHHHHHHHHHHCCC | 36.86 | 10092517 | |
| 724 | Ubiquitination | EAIIQIMKMRKKISN HHHHHHHHHHHHCCC | 36.86 | 23000965 | |
| 727 | Ubiquitination | IQIMKMRKKISNAQL HHHHHHHHHCCCHHH | 51.46 | 23000965 | |
| 728 | Ubiquitination | QIMKMRKKISNAQLQ HHHHHHHHCCCHHHH | 40.79 | 23000965 | |
| 730 | Phosphorylation | MKMRKKISNAQLQTE HHHHHHCCCHHHHHH | 34.69 | 19917606 | |
| 765 | Phosphorylation | EWLIEHKYIRRDESD HHHHHCCCCCCCHHH | 11.10 | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 730 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 730 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 730 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CUL5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CUL5_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210, AND MASSSPECTROMETRY. | |